Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Abbott, Add, albumin, answered, antitrypsin, APB, ARALAST, ARC, arrived, asserting, assumption, Austrian, authorization, authorized, bear, behavior, Belgium, biopharmaceutical, Bloomington, Boston, Bulletin, chronic, commence, computation, contemplation, convenience, converting, costly, counterpart, cumulative, curve, customer, cycle, declaration, deliver, depreciation, dividend, dominant, eleven, embedded, emphysema, England, equal, exceeded, expansion, experience, exposed, flow, grantee, greater, hereditary, High, highly, hybrid, immaterial, Indiana, inhibitor, injectable, Intersegment, invalidate, irreversible, life, London, Los, manual, Meridian, modified, modify, nonvested, open, outlined, overnight, packaging, parallel, pipeline, preliminary, proportion, protection, publicly, published, quoted, ratably, recognition, reconciled, reconstituted, reconstitution, recover, regeneration, reorganized, repayable, retained, revocation, revoke, RSU, ruled, SAB, safely, satisfactory, scale, selecting, sevoflurane, sleep, solution, stage, streamlined, stronger, subscription, TheMedication, thereon, tissue, Tokyo, unaffiliated, understand, unpredictability, upgrade, version, vest, vested, vesting, week, weighting
Removed:
acceleration, accumulated, actuarial, actuarially, adjustment, Alabama, alleging, andRenal, anesthesia, application, approval, approved, Arizona, arrangement, assessing, assuming, back, base, BBB, building, calculated, calculation, close, closed, collateral, combination, commercialization, competitively, concurrent, contingent, count, coupled, covenant, creation, differential, discount, distribute, divest, divided, downgrade, drawn, earlier, effectively, efficiency, enacted, enhance, entirety, equivalent, establishment, Europe, event, exclusive, executed, execution, expect, external, favorably, field, filing, final, floating, gain, hemoglobin, ii, iii, impairment, implemented, incentive, indefinite, individually, integrated, involve, Japan, law, limited, local, meet, Midwest, mirrored, Modernization, Montana, moved, negatively, Nevada, obligation, operationsDiscontinued, opposed, outlook, pain, paper, post, posted, prescription, processing, production, profitability, proprietary, protein, rating, reclassification, reevaluated, Regional, regulation, reissued, removed, repatriate, replenishment, represent, requested, retiree, Revenue, rolling, sealant, seasonality, secondary, securitize, served, settle, Shared, Similarly, SIP, solitary, spend, storage, strategy, subsidy, testing, Therapeutic, tool, trust, uncertainty, undertook, vary, virtue, voluntarily, voluntary, Wisconsin, worldwide
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 15 Letter Re Unaudited Interim Financial Information
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A)/15D-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A)/15D-14(A)
- 32.1 Certification of CEO Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification of CFO Pursuant to 18 U.s.c. Section 1350
Related press release
BAX similar filings
Filing view
External links
EXHIBIT 15
May 2, 2006
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
100 F Street, N.E.
Washington, D.C. 20549
Commissioners:
We are aware that our report dated May 2, 2006 on our review of interim financial information of Baxter International Inc. (the “Company”) as of March 31, 2006 and for the three-month periods ended March 31, 2006 and 2005 included in the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2006 is incorporated by reference in its Registration Statements on Form S-8 (Nos. 33-8813, 33-15523, 33-15787, 33-28428, 33-33750, 33-54069, 333-43563, 333-47019, 333-71553, 333-80403, 333-88257, 333-48906, 333-62820, 333-102140, 333-104420, 333-104421 and 333-105032), on Form S-3 (Nos. 33-5044, 33-23450, 333-54014, 333-106041 and 333-123811) and on Form S-4 (Nos. 33-808, 33-15357, 33-53937, 333-36670 and 333-133449-01).
Very truly yours,
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Chicago, Illinois
PricewaterhouseCoopers LLP
Chicago, Illinois